Delivery Order SPE2DR25D3012-SPE2DR26F4C5Y
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,861.47 to AmerisourceBergen Drug Corp for Dorzolamide-Timolol 2-0.5% ophthalmic solution in 60-unit packaging. Issued on November 25, 2025, with completion targeted for November 26, 2025, this firm fixed-price delivery order represents a routine pharmaceutical procurement supporting military healthcare operations. The award carries no set-aside designation, reflecting competitive procurement practices. Performance will occur at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Dorzolamide-Timolol eye drops in 10ml units, with a contract ceiling value of $2,224.32. This non-set-aside, firm fixed-price delivery order is scheduled for completion by September 11, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Dorzolamide-Timolol eye drops in 10ml quantities under a firm fixed-price contract valued at $4,762.14. This delivery order, which carries a completion date of November 21, 2025, represents a non-set-aside competitive award and serves as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at...
- The Defense Logistics Agency awarded a delivery order valued at $1,813.11 to AmerisourceBergen Drug Corp for the supply of Dorzolamide-Timolol Eye Drops (10ml) on November 10, 2025, with an ultimate completion date of November 12, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting...
- The Defense Logistics Agency awarded a delivery order valued at $4,258.38 to AmerisourceBergen Drug Corp for Dorzolamide-Timolol eye drops (10ml) with an ultimate completion date of August 14, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order valued at $4,475.58 to AmerisourceBergen Drug Corp for the supply of Dorzolamide-Timolol 2%-0.5% ophthalmic medication in 60-unit quantities. This non-set-aside, competitively awarded contract carries a firm fixed price and is scheduled for completion by August 6, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Dorzolamide-Timolol eye drops (10ml) with a contract ceiling value of $1,318.75. This is a firm fixed-price delivery order with an ultimate completion date of August 22, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical. The contract carries no set-aside designation, indicating it was...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 19, 2025, for the supply of Dorzolamide-Timolol eye drops in 10ML quantities, with a ceiling value of $7,944.73 and a firm fixed price structure. This contract represents a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 22, 2025. The award was issued to AmerisourceBergen's Corporate Office division, based in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a $9,144.21 firm fixed price delivery order to AmerisourceBergen Drug Corp for Dorzolamide-Timolol eye drops (10ml) on October 27, 2025, with an ultimate completion date of October 28, 2025. The order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $3,495.11 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Dorzolamide-Timolol eye drops in 10mL units, with an ultimate completion date of September 15, 2025. This non-set-aside contract was competitively awarded on September 12, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a delivery order issued under the company's larger Indefinite...
- SPE2DR25D3012Indefinite Delivery Contract
- SPE2DR25D3012-SPE2DR26F4C5YDelivery Order
The Defense Logistics Agency awarded a $4,057.15 delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Dorzolamide-Timolol 2-0.5% (preservative-free) in a 60-count package. This competitively awarded, firm fixed-price contract is a non-set-aside order with performance at the contractor's facility in Conshohocken, Pennsylvania, and is scheduled for completion by December 3, 2025. The pharmaceutical product is an ophthalmic medication used to treat glaucoma and elevated intraocular pressure. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of brand-name and generic medications, vaccines, and specialized medical supplies to support military healthcare programs worldwide. The contract reflects AmerisourceBergen's position as a critical pharmaceutical distributor for federal medical procurement, particularly supporting the Defense Health Agency and other government healthcare systems through flexible contract vehicles designed to meet diverse medical supply needs across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.1k | 12/1/25 |